• UK Clinical Trial Aims to Characterize Symptoms and Therapy Response in Gaucher Types 1 and 3
  • Newborn Screening Platform for Lysosomal Storage Diseases Granted CE Mark in Europe
  • Poor Bone Health in Gaucher Disease May Be Unrelated to the Condition Itself, Study Reports
  • Long-term Follow-up Needed to Assess Newborn Screening for Lysomal Storage Disorders
  • Sanofi Genzyme Planning Next Round of Scholarships for Students with Lysosomal Storage Disorders
  • Cerdelga a Viable Option to Treat Nonresponsive ERT Gaucher Symptoms, Case Study Suggests
  • Imaging Techniques Combo Helps Better Evaluate Bone Disease Risk in Gaucher Patients, Study Finds
  • Recommendations on Genetic Counseling for Gaucher-Parkinson’s Link Are Needed, Researchers Argue
  • FDA, EMA Propose Exploring Innovative Solutions for Gaucher Disease Drug Development
  • Hearing Loss in Gaucher Disease Type 1 Patient Improved with Cochlear Implants
  • Excessive Anger, Aggressiveness Are Behavioral Symptoms of Gaucher Disease Type 3, Study Finds
  • Taliglucerase Alfa Therapy Seen as Safe and Effective for Children with Gaucher Disease Type 1, Review Finds